Endra Life Sciences Reports Q1 GAAP EPS of -$1.09
Endra Life Sciences (NDRA) reported a Q1 GAAP earnings per share loss of $1.09 as of March 31, 2026. The company had approximately $356,000 in cash and an additional $2.4 million held in its Digital Asset Treasury.
Tickers: $NDRA
Topics: cash_position digital_assets financials